ZENITHDRUG — Zenith Drugs Cashflow Statement
0.000.00%
- IN₹1.34bn
- IN₹1.72bn
- IN₹1.32bn
- 13
- 40
- 50
- 23
Annual cashflow statement for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Net Income/Starting Line | 44.1 | 66.6 | 134 |
Depreciation | |||
Non-Cash Items | 21.4 | 23.1 | 30 |
Other Non-Cash Items | |||
Changes in Working Capital | -27.2 | -150 | -308 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 51.5 | -47.7 | -130 |
Capital Expenditures | -52.4 | -55.7 | -53.3 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | -0.001 | 53 | 313 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -52.4 | -2.69 | 260 |
Financing Cash Flow Items | -20.9 | -23.1 | -30 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 12.4 | 49.9 | -44.7 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 11.5 | -0.476 | 85.2 |